to determine the value of dopamine transporter (DAT) neuroimaging radiotracer ina group of idiopathic rapid eye movement sleep behavior disorder (iRBD) patientsregarding the development of a synucleinopathy. This evidence concerns the gene SLC6A3 and synucleinopathy.